0001415889-24-015750.txt : 20240606
0001415889-24-015750.hdr.sgml : 20240606
20240606162019
ACCESSION NUMBER: 0001415889-24-015750
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240528
FILED AS OF DATE: 20240606
DATE AS OF CHANGE: 20240606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yoon Derek
CENTRAL INDEX KEY: 0001674295
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41259
FILM NUMBER: 241025325
MAIL ADDRESS:
STREET 1: C/O CLEARSIDE BIOMEDICAL, INC.
STREET 2: 1220 OLD ALPHARETTA ROAD, SUITE 300
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcellx, Inc.
CENTRAL INDEX KEY: 0001786205
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472855917
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 BRIDGE PARKWAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 240-327-0603
MAIL ADDRESS:
STREET 1: 800 BRIDGE PARKWAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
4
1
form4-06062024_080616.xml
X0508
4
2024-05-28
0001786205
Arcellx, Inc.
ACLX
0001674295
Yoon Derek
C/O ARCELLX, INC.
800 BRIDGE PARKWAY
REDWOOD CITY
CA
94065
true
false
false
false
0
Stock Option (right to buy)
51.30
2024-05-28
4
A
0
8011
0
A
2034-05-28
Common Stock
8011
8011
D
Subject to the reporting person's continuing to be a Service Provider (as defined in the 2022 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of May 28, 2025 or the next annual meeting of stockholders.
/s/ Michelle Gilson, as Attorney-in-Fact
2024-06-06